| PERIOD ENDING | 30-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 95,473 | 91,005 | 95,572 | 84,026 | | Cost of Revenue | 78,764 | 72,733 | 77,695 | 68,846 | | | Gross Profit | 16,709 | 18,272 | 17,877 | 15,180 | | | Operating Expenses | | Research Development | 2,512 | 2,340 | 2,366 | 1,772 | | Selling General and Administrative | 4,537 | 6,400 | 6,128 | 5,788 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,660 | 9,532 | 9,383 | 7,620 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 9,646 | 9,532 | 9,383 | 7,620 | | Interest Expense | (21) | (4) | 11 | 14 | | Income Before Tax | 9,667 | 9,536 | 9,372 | 7,606 | | Income Tax Expense | 3,573 | 2,944 | 3,556 | 2,417 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,094 | 6,592 | 5,816 | 5,189 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,094 | 6,592 | 5,816 | 5,189 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,094 | $6,592 | $5,816 | $5,189 |
|
0.10% Nasdaq 
0.15%
Income Statement
